Objective To determine the clinical characteristics of infants ≤2 months old hospitalised with infl uenza A. Study design The study was a retrospective analysis of infants ≤2 months old hospitalised with fever, respiratory distress and/or sepsis. Clinical signs, laboratory values, hospital duration and outcome were compared between children with infl uenza A and other viruses. Results The charts of 268 infants were reviewed. 29 (11%) children had laboratory-confi rmed infl uenza A infection. Unique features associated with infl uenza infection included the high number presenting with fever (97%) and a history of exposure to family members with a fl u-like illness (69%). A signifi cantly lower rate of respiratory distress was observed in the infl uenza group compared with respiratory syncytial virus (RSV) (24% vs 89%, p≤0.001). Median duration of hospitalisation for infl uenza was shorter than RSV (4 days vs 6 days, p<0.001). Conclusions In young infants, infl uenza A is a relatively mild disease compared to RSV and is primarily associated with upper respiratory tract manifestations.
INTRODUCTION
Infl uenza A infection during infancy is a significant burden for the health system despite the increased rate of vaccination. 1 Infants infected during the fi rst year of life have a higher rate of hospital admissions, a greater number of complications compared with children of other age groups and adults, and a higher mortality rate. With regard to the fi rst 2 months of life, very few studies evaluated the severity of infl uenza infections as these infants may be relatively protected through transfer of maternal antibodies. 2 In the present study we aimed to study the clinical characteristics of infl uenza A infections in infants ≤2 months and compare them with infants with other respiratory viruses, including respiratory syncytial virus (RSV).
METHODS
The study was conducted at the Paediatric Departments of the Hadassah Medical Center, Jerusalem during the calendar year 2003. To be eligible the child had to be 2 months of age or younger (≤62 days), and be hospitalised for either: (1) acute respiratory disease defi ned as tachypnoea, hypoxia or respiratory distress; (2) acute life-threatening event; or (3) clinical suspicion of sepsis based on fever, changes in mental status or other manifestations associated with bacterial infections. Demographic and clinical information was obtained from the chart
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David Rekhtman, 1 Dana G Wolf, 2 Floris Levy-Khademi, 1 Diana Averbuch, 3 Eitan Kerem, 1 Isaiah D Wexler 1 including whether there was a history of exposure to specifi c viral pathogens. Viral studies were performed for all children and bacterial/ radiology studies when clinically indicated. Nasal wash specimens were analysed for the presence of RSV, infl uenza A and B, parainfl uenza and adenovirus by direct immunofl uorescence assay. Antigenic typing and subtyping of infl uenza virus isolates was performed by haemagglutination inhibition. The study was approved by and performed in adherence to the guidelines of the Hadassah-Hebrew University Medical Center Institutional Review Board. The data was analysed using both parametric and non-parametric statistics. For non-parametric variables, a χ 2 or Fisher's exact test was used. Interval-ratio data were compared using the Student's t test, and the Mann-Whitney rank sum test was used for comparison of data that were not normally distributed.
RESULTS
During the course of the study, 268 hospitalised children meeting the study eligibility criteria were evaluated. Of these, 29% had a background illness and 27% had a history of exposure to an individual with a viral illness. The microbiologic distribution of pathogens is shown in fi gure 1. For a majority (55%), no pathogen was identifi ed, for a minority (7.5%), bacteria could be isolated and for the remainder (38%) either a viral or combined viral/bacterial source for infection was determined. For all 101 children with positive viral tests, RSV was the major pathogen detected (n=53) followed by infl uenza A (n=29). Subtyping of infl uenza isolates showed that they were identical to A/Fujian/411/02-like viruses circulating during the latter half of 2003.
Clinical, laboratory, radiological and outcome variables of infl uenza A infection were compared to other viral infections (RSV, adenovirus, parainfl uenza), in general, and RSV infection, in particular (table 1) .
Over two-thirds of children with infl uenza A had a history of exposure to a family member with upper respiratory symptoms; in contrast, for RSV only 20% and for other viruses only 44% had a history of exposure (infl uenza vs RSV, p≤0.001). A slight male dominance was observed in children hospitalised with infl uenza infections. Fever >38°C was a nearly invariable fi nding among children with infl uenza A infections (97%), but was only found in 46% with RSV (infl uenza vs RSV, p≤0.001). Although a higher percentage of children had central nervous system manifestations (sleepiness or excessive irritability) in the children having respiratory distress, hypoxia, pneumonia and/ or upper respiratory manifestations.
There are several possibilities for the milder course of infl uenza A compared to RSV. Recent evidence suggests that the incidence and severity of infl uenza in the fi rst 6 months of life is reduced as a result of maternal immunisation during pregnancy. 2 Another possibility is that the immune response to infl uenza infections is different from that of RSV. 3 For example, Welliver et al showed that compared with RSV, infants with infl uenza had higher levels of lymphocyte-derived cytokines including interleukin (IL)-2, IL-4, interferon γ and IL-17 in nasopharyngeal secretions. More CD-8 positive lymphocytes/natural killer cells as well as a smaller viral load were detected in pathologic specimens from lungs of infants who died of infl uenza. 4 With the introduction of rapid antigen testing, it is now possible to identify infl uenza infections quickly. Based on the fairly mild course of infl uenza A in infants and studies showing signifi cantly reduced serious bacterial infections in infants ≥28 days, it has been argued that the management of young infants with infl uenza infections should be changed in terms of performing less extensive laboratory and radiological studies. 5 While our study is supportive of the fact that infl uenza infections are relatively mild in young infants, over 10% of the infants in our study had a coexisting serious bacterial infection. This would suggest caution before changing the management of febrile young infants with confi rmed infl uenza infections.
Competing interests None.
Ethics approval This study was conducted with the approval of the Hadassah Medical Center Institutional Review Board.
Provenance and peer review Not commissioned; externally peer reviewed.
infl uenza group compared with RSV (24% vs 9%), this was not signifi cant.
A signifi cant number of children with infl uenza A had bacterial co-infections. Blood cultures and urinalyses were performed for all patients with infl uenza infection, and for 21 children, cerebrospinal fl uid specimens were obtained as well. Three of 29 children (10%) had a concurrent urinary tract infection associated with positive cultures for bacterial pathogens (two with Group B Streptococcus and one with Staphylococcus aureus), in contrast to RSV infections where only 3/54 (6%) had a concurrent serious bacterial infection. Three other children had acute otitis media. A small number of children with infl uenza infection (14%) had a background illness including gastro-oesophageal refl ux, history of urinary tract infection, congenital stridor and failure to thrive.
Pulmonary involvement of children with infl uenza A was milder than with RSV or other viruses (table 1) . Fewer children with infl uenza A showed respiratory distress compared with those with RSV (24.1% vs 88.9%, p≤0.001). Similar significant differences were seen for hypoxia. Of the patients who had chest radiographs, none of the children with infl uenza A had pneumonia (one patient had atelectasis) compared with 17 out of 44 RSV patients. Infl uenza A patients did have hyperinfl ation suggestive of reactive airway disease, but this was relatively mild compared with RSV patients, as only a small number of infants with infl uenza suffered from either hypoxia and/or respiratory distress.
Outcome for patients with infl uenza based on time to discharge was better as patients with infl uenza were hospitalised for a median of 4 days compared with 6 days for RSV (p<0.001). For other outcome variables for example, time to defervescence, number of intensive care admissions and invasive pulmonary procedures, no differences were seen between infl uenza and RSV groups (table 1) . No fatalities among the children hospitalised for infl uenza A occurred and only one child with infl uenza A, a 28-day-old female, was admitted to the paediatric intensive care unit because of repeat cyanotic events and hypoxia, complicated by persistent gastro-oesophageal refl ux.
DISCUSSION
Infl uenza A was the second most frequent cause for hospitalisation after RSV in young infants (≤2 months) hospitalised for respiratory distress, fever, apparent life-threatening event or clinical suspicion of sepsis. Compared with RSV infants with infl uenza A had a milder disease with signifi cantly fewer 
